CARING FOR PATIENTS WITH CANCER:@0.084848:0.038601:0.499679:0.038601:0.499679:0.019343:0.084848:0.019343:0.019121:0.017404:0.014276:0.005315:0.017404:0.020508:0.006515:0.011406:0.020438:0.014276:0.006515:0.012154:0.015492:0.010019:0.005315:0.012606:0.017404:0.010019:0.011712:0.006515:0.022578:0.005315:0.010019:0.016063:0.006515:0.019121:0.017404:0.017404:0.019121:0.012606:0.014276
116:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
lymph  nodes  or  mediastinal  structures,  or :@0.084848:0.096166:0.481092:0.096166:0.481092:0.080410:0.084848:0.080410:0.003656:0.010122:0.017857:0.012931:0.011545:0.005330:0.003835:0.011545:0.012411:0.012989:0.012315:0.007274:0.005330:0.003835:0.012411:0.005600:0.005330:0.003835:0.017857:0.012315:0.012989:0.003656:0.012950:0.007274:0.006331:0.003656:0.011545:0.012950:0.003656:0.005330:0.003835:0.007274:0.006331:0.005600:0.011507:0.012257:0.006331:0.011507:0.005521:0.012315:0.007274:0.005138:0.005330:0.003835:0.012411:0.005788:0.005330
from  thrombosis  within  the  SVC,  as  may :@0.084848:0.112583:0.481088:0.112583:0.481088:0.096827:0.084848:0.096827:0.005850:0.005519:0.012411:0.017857:0.005330:0.005453:0.006331:0.011545:0.005519:0.012411:0.017857:0.012931:0.012411:0.007274:0.003656:0.007274:0.005330:0.005451:0.015798:0.003656:0.006331:0.011545:0.003656:0.011545:0.005330:0.005453:0.006331:0.011545:0.012315:0.005330:0.005453:0.009390:0.013316:0.015452:0.005138:0.005330:0.005453:0.012950:0.007274:0.005330:0.005453:0.017857:0.012950:0.010316:0.005330
result  from  central  venous  catheters.  An :@0.084848:0.129000:0.481117:0.129000:0.481117:0.113244:0.084848:0.113244:0.005521:0.012315:0.007274:0.011507:0.003656:0.006331:0.005330:0.005607:0.005850:0.005521:0.012411:0.017857:0.005330:0.005607:0.012257:0.012315:0.011545:0.006331:0.005600:0.012950:0.003656:0.005330:0.005607:0.010468:0.012315:0.011545:0.012411:0.011507:0.007274:0.005330:0.005607:0.012257:0.012950:0.006331:0.011545:0.012315:0.006331:0.012315:0.005600:0.007274:0.005138:0.005330:0.005605:0.014047:0.011734:0.005330
intrathoracic malignancy is responsible for :@0.084848:0.145418:0.481082:0.145418:0.481082:0.129662:0.084848:0.129662:0.003656:0.011545:0.006331:0.005600:0.012950:0.006331:0.011545:0.012411:0.005600:0.012950:0.012257:0.003656:0.012257:0.006927:0.017857:0.012950:0.003656:0.003656:0.012758:0.011545:0.012950:0.011545:0.012257:0.010122:0.006927:0.003656:0.007274:0.006927:0.005521:0.012315:0.007274:0.012931:0.012411:0.011545:0.007274:0.003656:0.012931:0.003656:0.012315:0.006927:0.005850:0.012411:0.005788:0.005330
between 60 and 85% of cases, with the re-:@0.084848:0.161835:0.475715:0.161835:0.475715:0.146079:0.084848:0.146079:0.012931:0.012315:0.006331:0.015798:0.012315:0.012315:0.011545:0.005753:0.010468:0.010468:0.005753:0.012950:0.011545:0.012989:0.005753:0.010468:0.010468:0.014720:0.005753:0.012411:0.005850:0.005753:0.012257:0.012950:0.007274:0.012315:0.007274:0.005138:0.005753:0.015798:0.003656:0.006331:0.011545:0.005753:0.006331:0.011545:0.012315:0.005753:0.005519:0.012315:0.006388
mainder resulting from thrombosis, fungal :@0.084848:0.178253:0.481124:0.178253:0.481124:0.162497:0.084848:0.162497:0.017857:0.012950:0.003656:0.011545:0.012989:0.012315:0.005600:0.009256:0.005521:0.012315:0.007274:0.011507:0.003656:0.006331:0.003656:0.011545:0.012758:0.009256:0.005850:0.005521:0.012411:0.017857:0.009256:0.006331:0.011545:0.005521:0.012411:0.017857:0.012931:0.012411:0.007274:0.003656:0.007274:0.005138:0.009256:0.005850:0.011507:0.011545:0.012758:0.012950:0.003852:0.005330
infections, fibrosing mediastinitis and post-:@0.084848:0.194670:0.475752:0.194670:0.475752:0.178914:0.084848:0.178914:0.003656:0.011545:0.005850:0.012315:0.012257:0.006331:0.003656:0.012411:0.011545:0.007274:0.005138:0.007836:0.004589:0.004589:0.012931:0.005521:0.012411:0.007274:0.003656:0.011545:0.012758:0.007836:0.017857:0.012315:0.012989:0.003656:0.012950:0.007274:0.006331:0.003656:0.011545:0.003656:0.006331:0.003656:0.007274:0.007836:0.012950:0.011545:0.012989:0.007836:0.012931:0.012411:0.007274:0.006331:0.006388
radiation fibrosis. The most common malig-:@0.084848:0.211087:0.475771:0.211087:0.475771:0.195331:0.084848:0.195331:0.005600:0.012950:0.012989:0.003656:0.012950:0.006331:0.003656:0.012411:0.011545:0.005623:0.004589:0.004589:0.012931:0.005521:0.012411:0.007274:0.003656:0.007274:0.005138:0.005621:0.008005:0.011545:0.012315:0.005621:0.017857:0.012411:0.007274:0.006331:0.005623:0.012257:0.012411:0.017857:0.017857:0.012411:0.011545:0.005623:0.017857:0.012950:0.003656:0.003656:0.012758:0.006388
nancies associated with SVC syndrome are :@0.084848:0.227505:0.481073:0.227505:0.481073:0.211749:0.084848:0.211749:0.011545:0.012950:0.011545:0.012257:0.003656:0.012315:0.007274:0.004489:0.012950:0.007274:0.007274:0.012411:0.012257:0.003656:0.012950:0.006331:0.012315:0.012989:0.004489:0.015798:0.003656:0.006331:0.011545:0.004489:0.009390:0.013316:0.015452:0.004489:0.007274:0.010122:0.011545:0.012989:0.005521:0.012411:0.017857:0.012315:0.004489:0.012950:0.005521:0.012506:0.005330
small-cell and non-small-cell lung cancers :@0.084848:0.243922:0.481069:0.243922:0.481069:0.228166:0.084848:0.228166:0.007274:0.017857:0.012950:0.003656:0.003656:0.006196:0.012257:0.012315:0.003656:0.003656:0.007726:0.012950:0.011545:0.012989:0.007726:0.011545:0.012411:0.011545:0.006196:0.007274:0.017857:0.012950:0.003656:0.003656:0.006196:0.012257:0.012315:0.003656:0.003656:0.007724:0.003656:0.011507:0.011545:0.012758:0.007726:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.007468:0.005330
and lymphoma. Together, these account :@0.084848:0.260340:0.481138:0.260340:0.481138:0.244584:0.084848:0.244584:0.012950:0.011545:0.012989:0.009082:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.005138:0.009082:0.007060:0.012411:0.012758:0.012315:0.006331:0.011545:0.012315:0.003575:0.005138:0.009082:0.006331:0.011545:0.012315:0.007274:0.012315:0.009082:0.012950:0.012257:0.012257:0.012411:0.011507:0.011545:0.006521:0.005330
for approximately 95% of cases. Other ma-:@0.084848:0.276757:0.475735:0.276757:0.475735:0.261001:0.084848:0.261001:0.005850:0.012411:0.005600:0.005619:0.012950:0.012931:0.012931:0.005519:0.012411:0.009044:0.003656:0.017857:0.012950:0.006331:0.012315:0.003656:0.010122:0.005619:0.010468:0.010468:0.014720:0.005619:0.012411:0.005850:0.005619:0.012257:0.012950:0.007274:0.012315:0.007274:0.005138:0.005619:0.016529:0.006331:0.011545:0.012315:0.005600:0.005619:0.017857:0.012950:0.006388
lignancies which may be associated in-:@0.084848:0.293174:0.475719:0.293174:0.475719:0.277418:0.084848:0.277418:0.003656:0.003656:0.012758:0.011545:0.012950:0.011545:0.012257:0.003656:0.012315:0.007274:0.011257:0.015798:0.011545:0.003656:0.012257:0.011545:0.011257:0.017857:0.012950:0.010122:0.011257:0.012931:0.012315:0.011257:0.012950:0.007274:0.007274:0.012411:0.012257:0.003656:0.012950:0.006331:0.012315:0.012989:0.011257:0.003656:0.011545:0.006388
clude any tumour which has metastasised :@0.084848:0.309592:0.481084:0.309592:0.481084:0.293836:0.084848:0.293836:0.012257:0.003656:0.011507:0.012989:0.012315:0.006415:0.012950:0.011545:0.010122:0.006415:0.006331:0.011507:0.017857:0.012411:0.011507:0.005600:0.006413:0.015798:0.011545:0.003656:0.012257:0.011545:0.006413:0.011545:0.012950:0.007274:0.006415:0.017857:0.012315:0.006331:0.012950:0.007274:0.006331:0.012950:0.007274:0.003656:0.007274:0.012315:0.013181:0.005330
to the mediastinal lymph nodes, mesothe-:@0.084848:0.326009:0.475796:0.326009:0.475796:0.310253:0.084848:0.310253:0.006331:0.012411:0.006523:0.006331:0.011545:0.012315:0.006523:0.017857:0.012315:0.012989:0.003656:0.012950:0.007274:0.006331:0.003656:0.011545:0.012950:0.003656:0.006523:0.003656:0.010122:0.017857:0.012931:0.011545:0.006523:0.011545:0.012411:0.012989:0.012315:0.007274:0.005138:0.006523:0.017857:0.012315:0.007274:0.012411:0.006331:0.011545:0.012315:0.006388
lioma, thymoma and germ-cell tumours in-:@0.084848:0.342427:0.475789:0.342427:0.475789:0.326671:0.084848:0.326671:0.003656:0.003656:0.012411:0.017857:0.012950:0.005138:0.005503:0.006331:0.011545:0.010122:0.017857:0.012411:0.017857:0.012950:0.005494:0.012950:0.011545:0.012989:0.005494:0.012758:0.012315:0.006131:0.017857:0.006196:0.012257:0.012315:0.003656:0.003656:0.005503:0.006331:0.011507:0.017857:0.012411:0.011507:0.005600:0.007274:0.005503:0.003656:0.011545:0.006388
volving the mediastinum. Importantly, this is :@0.084848:0.358844:0.481119:0.358844:0.481119:0.343088:0.084848:0.343088:0.010468:0.012411:0.003656:0.010468:0.003656:0.011545:0.012758:0.004753:0.006331:0.011545:0.012315:0.004753:0.017857:0.012315:0.012989:0.003656:0.012950:0.007274:0.006331:0.003656:0.011545:0.011507:0.017857:0.005138:0.004753:0.004156:0.017857:0.012931:0.012411:0.005600:0.006331:0.012950:0.011545:0.006331:0.003656:0.010122:0.005138:0.004743:0.006331:0.011545:0.003656:0.007274:0.004753:0.003656:0.007468:0.005330
the presenting symptom in roughly 60% of :@0.084848:0.375261:0.481121:0.375261:0.481121:0.359505:0.084848:0.359505:0.006331:0.011545:0.012315:0.007158:0.012931:0.005519:0.012315:0.007274:0.012315:0.011545:0.006331:0.003656:0.011545:0.012758:0.007158:0.007274:0.010122:0.017857:0.012931:0.006331:0.012411:0.017857:0.007158:0.003656:0.011545:0.007158:0.005521:0.012411:0.011507:0.012758:0.011545:0.003656:0.010122:0.007158:0.010468:0.010468:0.014720:0.007158:0.012411:0.006042:0.005330
patients with SVC syndrome.:@0.084848:0.391679:0.344444:0.391679:0.344444:0.375923:0.084848:0.375923:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005138:0.015798:0.003656:0.006331:0.011545:0.005138:0.009390:0.013316:0.015452:0.005138:0.007274:0.010122:0.011545:0.012989:0.005519:0.012411:0.017857:0.012315:0.005330
15:@0.344245:0.386007:0.356563:0.386007:0.356563:0.376822:0.344245:0.376822:0.006103:0.006215
PRESENTING SIGNS AND SYMPTOMS:@0.084848:0.424779:0.446606:0.424779:0.446606:0.406963:0.084848:0.406963:0.011973:0.012401:0.011118:0.011118:0.011118:0.015822:0.008980:0.005987:0.015822:0.017960:0.005987:0.011118:0.005987:0.017960:0.015822:0.011118:0.005987:0.015822:0.015822:0.014966:0.005987:0.011118:0.013256:0.019242:0.011973:0.008980:0.017960:0.019242:0.011118
The rate of onset of symptoms is related to :@0.084848:0.442340:0.481115:0.442340:0.481115:0.426584:0.084848:0.426584:0.008197:0.011738:0.012508:0.005109:0.005792:0.013143:0.006523:0.012508:0.005118:0.012604:0.006042:0.005118:0.012604:0.011738:0.007466:0.012508:0.006523:0.005118:0.012604:0.006042:0.005118:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005118:0.003848:0.007466:0.005118:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.005118:0.006523:0.012604:0.005330
the rate of obstruction of the SVC. Obstruc-:@0.084848:0.458757:0.475762:0.458757:0.475762:0.443001:0.084848:0.443001:0.006523:0.011738:0.012508:0.003645:0.005792:0.013143:0.006523:0.012508:0.003645:0.012604:0.006042:0.003646:0.012604:0.013123:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.003637:0.012604:0.006042:0.003646:0.006523:0.011738:0.012508:0.003645:0.009583:0.013508:0.015644:0.005330:0.003656:0.016722:0.013123:0.007466:0.006523:0.005792:0.011699:0.012450:0.006388
tion of blood flow within the SVC results in :@0.084848:0.475174:0.481086:0.475174:0.481086:0.459418:0.084848:0.459418:0.006523:0.003848:0.012604:0.011738:0.006279:0.012604:0.006042:0.006281:0.013123:0.003848:0.012604:0.012604:0.013181:0.006281:0.004666:0.004666:0.012604:0.015990:0.006281:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.006286:0.006523:0.011738:0.012508:0.006277:0.009583:0.013508:0.015644:0.006288:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.006288:0.003848:0.011738:0.005330
the dilation of venous collaterals. Despite :@0.084848:0.491592:0.481098:0.491592:0.481098:0.475836:0.084848:0.475836:0.006523:0.011738:0.012508:0.007050:0.013181:0.003848:0.003848:0.013154:0.006523:0.003848:0.012604:0.011738:0.007052:0.012604:0.006042:0.007062:0.010660:0.012508:0.011738:0.012604:0.011699:0.007466:0.007062:0.012450:0.012604:0.003848:0.003848:0.013143:0.006523:0.012508:0.005792:0.013143:0.003848:0.007466:0.005330:0.007062:0.014316:0.012508:0.007466:0.013123:0.003848:0.006523:0.012508:0.005330
this, pressure within the venous system re-:@0.084848:0.508009:0.475783:0.508009:0.475783:0.492253:0.084848:0.492253:0.006523:0.011738:0.003848:0.007466:0.005330:0.006956:0.013123:0.005715:0.012508:0.007466:0.007466:0.011699:0.005719:0.012508:0.006956:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.006966:0.006523:0.011738:0.012508:0.006950:0.010660:0.012508:0.011738:0.012604:0.011699:0.007466:0.006966:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.006966:0.005713:0.012508:0.006388
mains elevated and interstitial oedema of :@0.084848:0.524426:0.481103:0.524426:0.481103:0.508671:0.084848:0.508671:0.018049:0.013143:0.003848:0.011738:0.007466:0.005503:0.012508:0.003848:0.012508:0.010660:0.013143:0.006523:0.012508:0.013181:0.005503:0.013143:0.011738:0.013181:0.005494:0.003848:0.011738:0.006523:0.012508:0.005792:0.007466:0.006523:0.003848:0.006523:0.003848:0.013143:0.003848:0.005503:0.012604:0.012508:0.013181:0.012508:0.018049:0.013143:0.005490:0.012604:0.006042:0.005330
the head, neck and upper limbs develops. :@0.084848:0.540844:0.481092:0.540844:0.481092:0.525088:0.084848:0.525088:0.006523:0.011738:0.012508:0.004330:0.011738:0.012508:0.013143:0.013181:0.005330:0.004335:0.011738:0.012508:0.012450:0.009660:0.004335:0.013143:0.011738:0.013181:0.004337:0.011699:0.013123:0.013123:0.012508:0.005792:0.004333:0.003848:0.003848:0.018049:0.013123:0.007466:0.004349:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.007466:0.005330:0.005330
This oedema may compromise the upper :@0.084848:0.557261:0.481098:0.557261:0.481098:0.541505:0.084848:0.541505:0.008197:0.011738:0.003848:0.007466:0.006550:0.012604:0.012508:0.013181:0.012508:0.018049:0.013143:0.006542:0.018049:0.013143:0.010314:0.006562:0.012450:0.012604:0.018049:0.013123:0.005711:0.012604:0.018049:0.003848:0.007466:0.012508:0.006550:0.006523:0.011738:0.012508:0.006540:0.011699:0.013123:0.013123:0.012508:0.005792:0.005330
aerodigestive tract, and accounts for the :@0.084848:0.573679:0.481115:0.573679:0.481115:0.557923:0.084848:0.557923:0.013143:0.012508:0.005713:0.012604:0.013181:0.003848:0.012950:0.012508:0.007466:0.006523:0.003848:0.010660:0.012508:0.006485:0.006523:0.005792:0.013143:0.012450:0.006523:0.005330:0.006467:0.013143:0.011738:0.013181:0.006485:0.013143:0.012450:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.006473:0.006042:0.012604:0.005792:0.006465:0.006523:0.011738:0.012508:0.005330
characteristic symptoms associated with :@0.084848:0.590096:0.481088:0.590096:0.481088:0.574340:0.084848:0.574340:0.012450:0.011738:0.013143:0.005792:0.013143:0.012450:0.006523:0.012508:0.005792:0.003848:0.007466:0.006523:0.003848:0.012450:0.009737:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.009737:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.009737:0.015990:0.003848:0.006523:0.011738:0.005330
the  syndrome. Typical  presenting  signs :@0.084848:0.606513:0.481078:0.606513:0.481078:0.590758:0.084848:0.590758:0.006523:0.011738:0.012508:0.005330:0.008823:0.007466:0.010314:0.011738:0.013181:0.005713:0.012604:0.018049:0.012508:0.005321:0.014162:0.008286:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.005330:0.008844:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.005330:0.008821:0.007466:0.003848:0.012950:0.011738:0.007466:0.005330
and symptoms include swelling of the neck :@0.084848:0.622931:0.481103:0.622931:0.481103:0.607175:0.084848:0.607175:0.013143:0.011738:0.013181:0.003675:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.003675:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.003675:0.007466:0.015990:0.012508:0.003848:0.003848:0.003848:0.011738:0.012950:0.003675:0.012604:0.006042:0.003664:0.006523:0.011738:0.012508:0.003664:0.011738:0.012508:0.012450:0.009660:0.005330
and  upper  limbs. Oedema of  the  upper :@0.084848:0.639348:0.481098:0.639348:0.481098:0.623592:0.084848:0.623592:0.013143:0.011738:0.013181:0.005330:0.003531:0.011699:0.013123:0.013123:0.012508:0.005792:0.005330:0.003527:0.003848:0.003848:0.018049:0.013123:0.007466:0.005330:0.008871:0.016722:0.012508:0.013181:0.012508:0.018049:0.013143:0.008871:0.012604:0.006042:0.005330:0.003531:0.006523:0.011738:0.012508:0.005330:0.003525:0.011699:0.013123:0.013123:0.012508:0.005792:0.005330
airways results in stridor, cough,  hoarse-:@0.084848:0.655766:0.475775:0.655766:0.475775:0.640010:0.084848:0.640010:0.013143:0.003848:0.005792:0.015990:0.013143:0.010314:0.007466:0.011103:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.011103:0.003848:0.011738:0.011103:0.007466:0.006523:0.005792:0.003848:0.013181:0.012604:0.003766:0.005330:0.011103:0.012450:0.012604:0.011699:0.012950:0.011738:0.005330:0.005330:0.005759:0.011738:0.012604:0.013143:0.005792:0.007466:0.012508:0.006388
ness, dyspnoea and dysphagia. Cerebral :@0.084848:0.672183:0.481074:0.672183:0.481074:0.656427:0.084848:0.656427:0.011738:0.012508:0.007466:0.007466:0.005330:0.006933:0.013181:0.010314:0.007466:0.013123:0.011738:0.012604:0.012508:0.013143:0.006935:0.013143:0.011738:0.013181:0.006933:0.013181:0.010314:0.007466:0.013123:0.011738:0.013143:0.012950:0.003848:0.013143:0.005330:0.006937:0.015644:0.012508:0.005711:0.012508:0.013123:0.005792:0.013143:0.003848:0.005330
oedema typically results in headaches, :@0.084848:0.688600:0.481086:0.688600:0.481086:0.672844:0.084848:0.672844:0.012604:0.012508:0.013181:0.012508:0.018049:0.013143:0.011873:0.006523:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.011873:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.011873:0.003848:0.011738:0.011873:0.011738:0.012508:0.013143:0.013181:0.013143:0.012450:0.011738:0.012508:0.007466:0.005330:0.005330
and may result in cerebral ischaemia, her-:@0.084848:0.705018:0.475758:0.705018:0.475758:0.689262:0.084848:0.689262:0.013143:0.011738:0.013181:0.005157:0.018049:0.013143:0.010314:0.005157:0.005711:0.012508:0.007466:0.011699:0.003848:0.006523:0.005157:0.003848:0.011738:0.005157:0.012450:0.012508:0.005709:0.012508:0.013123:0.005792:0.013143:0.003848:0.005157:0.003848:0.007466:0.012450:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005157:0.011738:0.012508:0.005821:0.006388
niation and infrequently death. The diag-:@0.084848:0.721435:0.475754:0.721435:0.475754:0.705679:0.084848:0.705679:0.011738:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.007085:0.013143:0.011738:0.013181:0.007089:0.003848:0.011738:0.006042:0.005713:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.003848:0.010314:0.007087:0.013181:0.012508:0.013143:0.006523:0.011738:0.005330:0.007083:0.008197:0.011738:0.012508:0.007079:0.013181:0.003848:0.013143:0.012950:0.006388
nosis is made clinically, on the basis of the :@0.084848:0.737853:0.481090:0.737853:0.481090:0.722097:0.084848:0.722097:0.011738:0.012604:0.007466:0.003848:0.007466:0.005677:0.003848:0.007466:0.005677:0.018049:0.013143:0.013181:0.012508:0.005667:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.005677:0.012604:0.011738:0.005659:0.006523:0.011738:0.012508:0.005661:0.013123:0.013143:0.007466:0.003848:0.007466:0.005677:0.012604:0.006042:0.005663:0.006523:0.011738:0.012508:0.005330
above characteristic signs and symptoms :@0.084848:0.754270:0.481107:0.754270:0.481107:0.738514:0.084848:0.738514:0.013143:0.013123:0.012604:0.010660:0.012508:0.006523:0.012450:0.011738:0.013143:0.005792:0.013143:0.012450:0.006523:0.012508:0.005792:0.003848:0.007466:0.006523:0.003848:0.012450:0.006523:0.007466:0.003848:0.012950:0.011738:0.007466:0.006523:0.013143:0.011738:0.013181:0.006523:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330
and is confirmed by chest radiology. The :@0.084848:0.770687:0.481099:0.770687:0.481099:0.754931:0.084848:0.754931:0.013143:0.011738:0.013181:0.007526:0.003848:0.007466:0.007531:0.012450:0.012604:0.011738:0.004686:0.004686:0.006312:0.018049:0.012508:0.013181:0.007526:0.013123:0.010314:0.007530:0.012450:0.011738:0.012508:0.007466:0.006523:0.007520:0.005792:0.013143:0.013181:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.007522:0.008197:0.011738:0.012508:0.005330
majority of patients with SVC will  have :@0.084848:0.787105:0.481082:0.787105:0.481082:0.771349:0.084848:0.771349:0.018049:0.013143:0.003906:0.012604:0.005792:0.003848:0.006523:0.010314:0.011796:0.012604:0.006042:0.011796:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.011796:0.015990:0.003848:0.006523:0.011738:0.011796:0.009583:0.013508:0.015644:0.011796:0.015990:0.003848:0.003848:0.003848:0.005330:0.006479:0.011738:0.013143:0.010660:0.012508:0.005330
an abnormal chest radiograph, however :@0.084848:0.803522:0.481096:0.803522:0.481096:0.787766:0.084848:0.787766:0.013143:0.011738:0.007735:0.013143:0.013123:0.011738:0.012604:0.006319:0.018049:0.013143:0.003848:0.007735:0.012450:0.011738:0.012508:0.007466:0.006523:0.007735:0.005792:0.013143:0.013181:0.003848:0.012604:0.012950:0.005792:0.013143:0.013123:0.011738:0.005330:0.007735:0.011738:0.012604:0.015990:0.012508:0.010660:0.012508:0.005792:0.005330
the most useful investigation is a contrast-:@0.084848:0.819940:0.475758:0.819940:0.475758:0.804184:0.084848:0.804184:0.006523:0.011738:0.012508:0.006292:0.018049:0.012604:0.007466:0.006523:0.006292:0.011699:0.007466:0.012508:0.006042:0.011699:0.003848:0.006292:0.003848:0.011738:0.010660:0.012508:0.007466:0.006523:0.003848:0.012950:0.013143:0.006523:0.003848:0.012604:0.011738:0.006292:0.003848:0.007466:0.006292:0.013143:0.006292:0.012450:0.012604:0.011738:0.006523:0.005792:0.013143:0.007466:0.006523:0.006388
enhanced  CT  scan of  the  chest.  This will :@0.084848:0.836357:0.481088:0.836357:0.481088:0.820601:0.084848:0.820601:0.012508:0.011738:0.011738:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330:0.003100:0.015644:0.008197:0.005330:0.003104:0.007466:0.012450:0.013143:0.011738:0.008447:0.012604:0.006042:0.005330:0.003104:0.006523:0.011738:0.012508:0.005330:0.003100:0.012450:0.011738:0.012508:0.007466:0.006523:0.005330:0.005330:0.003102:0.008197:0.011738:0.003848:0.007466:0.008447:0.015990:0.003848:0.003848:0.003848:0.005330
detail the level and extent of obstruction, :@0.084848:0.852774:0.481128:0.852774:0.481128:0.837018:0.084848:0.837018:0.013181:0.012508:0.006523:0.013143:0.003848:0.003848:0.006388:0.006523:0.011738:0.012508:0.006388:0.003848:0.012508:0.010660:0.012508:0.003848:0.006388:0.013143:0.011738:0.013181:0.006388:0.012508:0.009236:0.006523:0.012508:0.011738:0.006523:0.006371:0.012604:0.006042:0.006388:0.012604:0.013123:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330
and the presence of associated thrombus.:@0.084848:0.869192:0.475760:0.869192:0.475760:0.853436:0.084848:0.853436:0.013143:0.011738:0.013181:0.004176:0.006523:0.011738:0.012508:0.004166:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.004166:0.012604:0.006042:0.004166:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.004176:0.006523:0.011738:0.005707:0.012604:0.018049:0.013123:0.011699:0.007466:0.005330
MANAGEMENT:@0.084848:0.902268:0.235794:0.902268:0.235794:0.884453:0.084848:0.884453:0.019242:0.015822:0.015822:0.015822:0.017960:0.011118:0.019242:0.011118:0.015822:0.008980
The goals of management  are to allevi-:@0.084848:0.919829:0.475758:0.919829:0.475758:0.904073:0.084848:0.904073:0.008197:0.011738:0.012508:0.009121:0.012950:0.012604:0.013143:0.003848:0.007466:0.009121:0.012604:0.006042:0.009121:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.003781:0.013143:0.005713:0.012508:0.009121:0.006523:0.012604:0.009121:0.013143:0.003848:0.003848:0.012508:0.010660:0.003860:0.006388
ate symptoms, prevent airway obstruction :@0.084848:0.936247:0.481094:0.936247:0.481094:0.920491:0.084848:0.920491:0.013143:0.006523:0.012508:0.005109:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330:0.005107:0.013123:0.005717:0.012508:0.010660:0.012508:0.011738:0.006523:0.005105:0.013143:0.003848:0.005792:0.015990:0.013143:0.010314:0.005118:0.012604:0.013123:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330
or  cerebral compromise, and treat  the :@0.524249:0.096168:0.920513:0.096168:0.920513:0.080412:0.524249:0.080412:0.012604:0.005792:0.005330:0.006356:0.012450:0.012508:0.005709:0.012508:0.013123:0.005792:0.013143:0.003848:0.011699:0.012450:0.012604:0.018049:0.013123:0.005715:0.012604:0.018049:0.003848:0.007466:0.012508:0.005330:0.011699:0.013143:0.011738:0.013181:0.011699:0.006523:0.005711:0.012508:0.013143:0.006523:0.005330:0.006360:0.006523:0.011738:0.012508:0.005330
underlying malignancy. Patients who pre-:@0.524249:0.112414:0.915179:0.112414:0.915179:0.096658:0.524249:0.096658:0.011699:0.011738:0.013181:0.012508:0.005792:0.003848:0.010314:0.003848:0.011738:0.012950:0.006388:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.010314:0.005330:0.006388:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006388:0.015990:0.011738:0.012604:0.006388:0.013123:0.005717:0.012508:0.006388
sent  with  stridor  due  to  severe laryngeal :@0.524249:0.128659:0.920490:0.128659:0.920490:0.112903:0.524249:0.112903:0.007466:0.012508:0.011738:0.006523:0.005330:0.003704:0.015990:0.003848:0.006523:0.011738:0.005330:0.003704:0.007466:0.006523:0.005792:0.003848:0.013181:0.012604:0.005792:0.005330:0.003702:0.013181:0.011699:0.012508:0.005330:0.003704:0.006523:0.012604:0.005330:0.003700:0.007466:0.012508:0.010660:0.012508:0.005713:0.012508:0.009044:0.003848:0.013143:0.005792:0.010314:0.011738:0.012950:0.012508:0.013143:0.003848:0.005330
oedema and occlusion, or  with coma, :@0.524249:0.144904:0.920515:0.144904:0.920515:0.129148:0.524249:0.129148:0.012604:0.012508:0.013181:0.012508:0.018049:0.013143:0.011757:0.013143:0.011738:0.013181:0.011757:0.012604:0.012450:0.012450:0.003848:0.011699:0.007466:0.003848:0.012604:0.011738:0.005330:0.011757:0.012604:0.005792:0.005330:0.006415:0.015990:0.003848:0.006523:0.011738:0.011757:0.012450:0.012604:0.018049:0.013143:0.005330:0.005330
represent a true medical emergency and :@0.524249:0.161150:0.920488:0.161150:0.920488:0.145394:0.524249:0.145394:0.005713:0.012508:0.013123:0.005713:0.012508:0.007466:0.012508:0.011738:0.006523:0.005907:0.013143:0.005907:0.006523:0.005792:0.011699:0.012496:0.005907:0.018049:0.012508:0.013181:0.003848:0.012450:0.013143:0.003848:0.005907:0.012508:0.018049:0.012508:0.005807:0.012950:0.012508:0.011738:0.012450:0.010314:0.005907:0.013143:0.011738:0.013181:0.005330
immediate treatment  with stent  place-:@0.524249:0.177395:0.915150:0.177395:0.915150:0.161639:0.524249:0.161639:0.003848:0.018049:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.012931:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.007591:0.015990:0.003848:0.006523:0.011738:0.012931:0.007466:0.006523:0.012508:0.011738:0.006523:0.005330:0.007589:0.013123:0.003848:0.013143:0.012450:0.012508:0.006388
ment  and/or  radiotherapy  is indicated. :@0.524249:0.193641:0.920484:0.193641:0.920484:0.177885:0.524249:0.177885:0.018049:0.012508:0.011738:0.006523:0.005330:0.006779:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330:0.006775:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.006781:0.003848:0.007466:0.012123:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.005330:0.005330
For others, emergency radiotherapy may :@0.524249:0.209886:0.920490:0.209886:0.920490:0.194130:0.524249:0.194130:0.009333:0.012604:0.005792:0.007293:0.012604:0.006523:0.011738:0.012496:0.005792:0.007466:0.005330:0.007299:0.012508:0.018049:0.012508:0.005807:0.012950:0.012508:0.011738:0.012450:0.010314:0.007297:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.007301:0.018049:0.013143:0.010314:0.005330
be deferred until a full diagnostic work-up :@0.524249:0.226131:0.920521:0.226131:0.920521:0.210375:0.524249:0.210375:0.013123:0.012508:0.005773:0.013181:0.012508:0.006042:0.012508:0.005792:0.005709:0.012508:0.013181:0.005773:0.011699:0.011738:0.006523:0.003848:0.003848:0.005773:0.013143:0.005773:0.006042:0.011699:0.003848:0.003848:0.005773:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.005773:0.015990:0.012604:0.005792:0.009660:0.006388:0.011699:0.013123:0.005330
has been concluded. This has not shown :@0.524249:0.242377:0.920498:0.242377:0.920498:0.226621:0.524249:0.226621:0.011738:0.013143:0.007466:0.007620:0.013123:0.012508:0.012508:0.011738:0.007620:0.012450:0.012604:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.013181:0.005330:0.007620:0.008197:0.011738:0.003848:0.007466:0.007620:0.011738:0.013143:0.007466:0.007620:0.011738:0.012604:0.006523:0.007610:0.007466:0.011738:0.012604:0.015990:0.011738:0.005330
to  negatively impact on treatment  out-:@0.524249:0.258622:0.915172:0.258622:0.915172:0.242866:0.524249:0.242866:0.006523:0.012604:0.005330:0.005032:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.003848:0.010314:0.010372:0.003848:0.018049:0.013123:0.013143:0.012450:0.006523:0.010372:0.012604:0.011738:0.010372:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005032:0.012604:0.011699:0.006523:0.006388
comes.  Evidence-based guidelines for :@0.524249:0.274868:0.920479:0.274838:0.920479:0.259082:0.524249:0.259112:0.012450:0.012604:0.018049:0.012508:0.007466:0.005330:0.012422:0.013008:0.010314:0.010660:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.006388:0.013123:0.013143:0.007466:0.012508:0.013181:0.013008:0.012950:0.011699:0.003848:0.013181:0.012508:0.003848:0.003848:0.011738:0.012508:0.007466:0.013008:0.006042:0.012604:0.005792:0.162549
16:@0.592643:0.269219:0.605073:0.269219:0.605073:0.260034:0.592643:0.260034:0.006215:0.006215
the  management  of  SVC are  not  avail-:@0.524240:0.291084:0.915149:0.291084:0.915149:0.275328:0.524240:0.275328:0.006523:0.011738:0.012508:0.005330:0.004524:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.004518:0.012604:0.006042:0.005330:0.004526:0.009583:0.013508:0.015644:0.009871:0.013143:0.005715:0.012508:0.005330:0.004530:0.011738:0.012604:0.006523:0.005330:0.004522:0.013143:0.010660:0.013143:0.003848:0.003858:0.006388
able, and  international  recommenda-:@0.524240:0.307329:0.915161:0.307329:0.915161:0.291573:0.524240:0.291573:0.013143:0.013123:0.003848:0.012508:0.005330:0.017068:0.013143:0.011738:0.013181:0.005330:0.011728:0.003848:0.011738:0.006523:0.012508:0.006190:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.011728:0.005713:0.012508:0.012450:0.012604:0.018049:0.018049:0.012508:0.011738:0.013181:0.013143:0.006388
tions support  radiotherapy and/or  stent :@0.524240:0.323574:0.920495:0.323574:0.920495:0.307818:0.524240:0.307818:0.006523:0.003848:0.012604:0.011738:0.007466:0.011776:0.007466:0.011699:0.013123:0.013123:0.012604:0.005792:0.006523:0.005330:0.006437:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.011776:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330:0.006433:0.007466:0.006523:0.012508:0.011738:0.006523:0.005330
placement.:@0.524240:0.339820:0.633460:0.339820:0.633460:0.324064:0.524240:0.324064:0.013123:0.003848:0.013143:0.012450:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330
17-19:@0.633458:0.334191:0.662042:0.334191:0.662042:0.325005:0.633458:0.325005:0.006215:0.006215:0.003724:0.006215:0.006215
 General measures include :@0.662051:0.339810:0.920478:0.339810:0.920478:0.324054:0.662051:0.324054:0.006319:0.016779:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.006317:0.018049:0.012508:0.013143:0.007466:0.011699:0.005713:0.012508:0.007466:0.006321:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330
nursing the patient in a semi-upright posi-:@0.524237:0.356056:0.915146:0.356056:0.915146:0.340300:0.524237:0.340300:0.011738:0.011699:0.005792:0.007466:0.003848:0.011738:0.012950:0.006896:0.006523:0.011738:0.012508:0.006895:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.006908:0.003848:0.011738:0.006908:0.013143:0.006908:0.007466:0.012508:0.018049:0.003848:0.006388:0.011699:0.013123:0.005792:0.003848:0.012950:0.011738:0.006523:0.006895:0.013123:0.012604:0.007466:0.003848:0.006388
tion, and face-mask oxygen may provide :@0.524237:0.372301:0.920476:0.372301:0.920476:0.356545:0.524237:0.356545:0.006523:0.003848:0.012604:0.011738:0.005330:0.006292:0.013143:0.011738:0.013181:0.006292:0.006042:0.013143:0.012450:0.012508:0.006388:0.018049:0.013143:0.007466:0.009660:0.006292:0.012604:0.009236:0.010314:0.012950:0.012508:0.011738:0.006292:0.018049:0.013143:0.010314:0.006292:0.013123:0.005715:0.012604:0.010660:0.003848:0.013181:0.012508:0.005330
symptomatic relief. Intravenous steroids :@0.524237:0.388546:0.920488:0.388546:0.920488:0.372790:0.524237:0.372790:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.013835:0.005711:0.012508:0.003848:0.003848:0.012508:0.006042:0.005330:0.013835:0.004349:0.011738:0.006523:0.005792:0.013143:0.010660:0.012508:0.011738:0.012604:0.011699:0.007466:0.013835:0.007466:0.006523:0.012508:0.005711:0.012604:0.003848:0.013181:0.007466:0.005330
are helpful in steroid-responsive  malig-:@0.524237:0.404792:0.915135:0.404792:0.915135:0.389036:0.524237:0.389036:0.013143:0.005715:0.012508:0.014259:0.011738:0.012508:0.003848:0.013123:0.006042:0.011699:0.003848:0.014259:0.003848:0.011738:0.014259:0.007466:0.006523:0.012508:0.005711:0.012604:0.003848:0.013181:0.006388:0.005715:0.012508:0.007466:0.013123:0.012604:0.011738:0.007466:0.003848:0.010660:0.012508:0.005330:0.008940:0.018049:0.013143:0.003848:0.003848:0.012950:0.006388
nancies such  as lymphoma and thymo-:@0.524237:0.421037:0.915175:0.421037:0.915175:0.405281:0.524237:0.405281:0.011738:0.013143:0.011738:0.012450:0.003848:0.012508:0.007466:0.009910:0.007466:0.011699:0.012450:0.011738:0.005330:0.004570:0.013143:0.007466:0.009910:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.009910:0.013143:0.011738:0.013181:0.009910:0.006523:0.011738:0.010314:0.018049:0.012604:0.006388
ma, and in association with radiotherapy :@0.524237:0.437283:0.920457:0.437283:0.920457:0.421527:0.524237:0.421527:0.018049:0.013143:0.005330:0.007216:0.013143:0.011738:0.013181:0.007216:0.003848:0.011738:0.007216:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.007216:0.015990:0.003848:0.006523:0.011738:0.007216:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
which may result in initial worsening of la-:@0.524237:0.453528:0.915154:0.453528:0.915154:0.437772:0.524237:0.437772:0.015990:0.011738:0.003848:0.012450:0.011738:0.006696:0.018049:0.013143:0.010314:0.006696:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.006696:0.003848:0.011738:0.006696:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.006696:0.015990:0.012604:0.005792:0.007466:0.012508:0.011738:0.003848:0.011738:0.012950:0.006679:0.012604:0.006042:0.006685:0.003848:0.013143:0.006388
ryngeal oedema. Diuretics may be used; :@0.524237:0.469773:0.920486:0.469773:0.920486:0.454017:0.524237:0.454017:0.005792:0.010314:0.011738:0.012950:0.012508:0.013143:0.003848:0.007524:0.012604:0.012508:0.013181:0.012508:0.018049:0.013143:0.005330:0.007512:0.014316:0.003848:0.011699:0.005717:0.012508:0.006523:0.003848:0.012450:0.007466:0.007524:0.018049:0.013143:0.010314:0.007524:0.013123:0.012508:0.007524:0.011699:0.007466:0.012508:0.013181:0.005330:0.005330
however, no prospective evidence exists :@0.524237:0.486019:0.920465:0.486019:0.920465:0.470263:0.524237:0.470263:0.011738:0.012604:0.015990:0.012508:0.010660:0.012508:0.003762:0.005330:0.008621:0.011738:0.012604:0.008621:0.013123:0.005713:0.012604:0.007466:0.013123:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.008621:0.012508:0.010660:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.008621:0.012508:0.009236:0.003848:0.007466:0.006523:0.007466:0.005330
to support their use.:@0.524237:0.502264:0.707097:0.502264:0.707097:0.486508:0.524237:0.486508:0.006523:0.012604:0.005330:0.007466:0.011699:0.013123:0.013123:0.012604:0.005792:0.006523:0.005330:0.006523:0.011738:0.012508:0.003848:0.005792:0.005330:0.011699:0.007466:0.012508:0.005330
Specific measures include radiotherapy :@0.542421:0.518510:0.920484:0.518510:0.920484:0.502754:0.542421:0.502754:0.009583:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.006621:0.018049:0.012508:0.013143:0.007466:0.011699:0.005715:0.012508:0.007466:0.006621:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.006623:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
alone,  or  in  combination  with  placing of :@0.524237:0.534755:0.920498:0.534755:0.920498:0.518999:0.524237:0.518999:0.013143:0.003848:0.012604:0.011738:0.012508:0.005330:0.005330:0.003040:0.012604:0.005792:0.005330:0.003042:0.003848:0.011738:0.005330:0.003048:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.003046:0.015990:0.003848:0.006523:0.011738:0.005330:0.003046:0.013123:0.003848:0.013143:0.012450:0.003848:0.011738:0.012950:0.008390:0.012604:0.006042:0.005330
an IVC stent. Chemosensitive tumours, :@0.524237:0.551000:0.920496:0.551000:0.920496:0.535245:0.524237:0.535245:0.013143:0.011738:0.014047:0.004349:0.013508:0.015644:0.014047:0.007466:0.006523:0.012508:0.011738:0.006523:0.005330:0.014047:0.015644:0.011738:0.012508:0.018049:0.012604:0.007466:0.012508:0.011738:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.014047:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005330
such as small-cell lung cancer, lymphoma :@0.524237:0.567246:0.920486:0.567246:0.920486:0.551490:0.524237:0.551490:0.007466:0.011699:0.012450:0.011738:0.005811:0.013143:0.007466:0.005811:0.007466:0.018049:0.013143:0.003848:0.003848:0.006388:0.012463:0.012508:0.003848:0.003848:0.005811:0.003848:0.011699:0.011738:0.012950:0.005811:0.012450:0.013143:0.011738:0.012450:0.012508:0.003768:0.005330:0.005811:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330
and germ-cell tumours are generally treat-:@0.524237:0.583491:0.915154:0.583491:0.915154:0.567735:0.524237:0.567735:0.013143:0.011738:0.013181:0.004272:0.012950:0.012508:0.006319:0.018049:0.006388:0.012450:0.012508:0.003848:0.003848:0.004272:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.004258:0.013143:0.005715:0.012508:0.004272:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.003848:0.010314:0.004272:0.006523:0.005709:0.012508:0.013143:0.006523:0.006388
ed with initial chemotherapy. In these ma-:@0.524237:0.599737:0.915154:0.599737:0.915154:0.583981:0.524237:0.583981:0.012508:0.013181:0.005022:0.015990:0.003848:0.006523:0.011738:0.005022:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.005022:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005001:0.004349:0.011738:0.005022:0.006523:0.011738:0.012508:0.007466:0.012508:0.005013:0.018049:0.013143:0.006388
lignancies, radiotherapy  may be added :@0.524237:0.615982:0.920484:0.615982:0.920484:0.600226:0.524237:0.600226:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.003848:0.012508:0.007466:0.005330:0.009506:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.004164:0.018049:0.013143:0.010314:0.009506:0.013123:0.012508:0.009506:0.013143:0.013181:0.013181:0.012508:0.013181:0.005330
and has shown to  decrease local recur-:@0.524237:0.632228:0.915166:0.632228:0.915166:0.616472:0.524237:0.616472:0.013143:0.011738:0.013181:0.008659:0.011738:0.013143:0.007466:0.008659:0.007466:0.011738:0.012604:0.015990:0.011738:0.008659:0.006523:0.012604:0.005330:0.003317:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.008659:0.003848:0.012604:0.012450:0.013143:0.003848:0.008659:0.005711:0.012508:0.012450:0.011699:0.005792:0.006388
rence rates and improve OS.:@0.524237:0.648473:0.792093:0.648473:0.792093:0.632717:0.524237:0.632717:0.005713:0.012508:0.011738:0.012450:0.012508:0.005330:0.005792:0.013143:0.006523:0.012508:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.003848:0.018049:0.013123:0.005700:0.012604:0.010660:0.012508:0.005330:0.016722:0.009583:0.005330
REFERENCES:@0.524237:0.678014:0.635073:0.678014:0.635073:0.661980:0.524237:0.661980:0.011161:0.010006:0.009236:0.010006:0.011161:0.010006:0.014239:0.015009:0.010006:0.010006
1. :@0.524242:0.694774:0.543193:0.694774:0.543193:0.680769:0.524242:0.680769:0.009476:0.004738:0.004738
  Hanna L, Crosby T and Macbeth F. :@0.560589:0.694774:0.860508:0.694774:0.860508:0.680769:0.560589:0.680769:0.004738:-0.004738:0.011682:0.011682:0.010434:0.010434:0.011682:0.006448:0.007902:0.004738:0.006448:0.013906:0.005078:0.011203:0.006636:0.011665:0.009168:0.006448:0.007286:0.006448:0.011682:0.010434:0.011716:0.006448:0.015719:0.011682:0.011067:0.011665:0.011118:0.005798:0.010434:0.006448:0.006941:0.004738:0.004738
Practi-:@0.862219:0.694774:0.915140:0.694774:0.915140:0.680769:0.862219:0.680769:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.005679
cal Clinical Oncology:@0.560589:0.708956:0.738337:0.708956:0.738337:0.694950:0.560589:0.694950:0.011067:0.011682:0.003421:0.003968:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.003968:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
. 2nd ed. Cambridge: :@0.738337:0.708956:0.919866:0.708956:0.919866:0.694950:0.738337:0.694950:0.004738:0.003968:0.009476:0.010434:0.011716:0.003968:0.011118:0.011716:0.004738:0.003968:0.013906:0.011682:0.016044:0.011665:0.005148:0.003421:0.011716:0.011511:0.011118:0.004738:0.004738
Cambridge University Press; 2015.:@0.560589:0.723137:0.833805:0.723137:0.833805:0.709132:0.560589:0.709132:0.013906:0.011682:0.016044:0.011665:0.005148:0.003421:0.011716:0.011511:0.011118:0.004738:0.011203:0.010434:0.003421:0.009476:0.011118:0.005148:0.006636:0.003421:0.005798:0.009168:0.004738:0.010126:0.005071:0.011118:0.006636:0.006636:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
2. :@0.524242:0.737319:0.543193:0.737319:0.543193:0.723314:0.524242:0.723314:0.009476:0.004738:0.004738
  Akram H, Allibone J. Spinal surgery for pal-:@0.560589:0.737319:0.915148:0.737319:0.915148:0.723314:0.560589:0.723314:0.004738:-0.004738:0.012657:0.008586:0.005148:0.011682:0.016044:0.005887:0.011682:0.004738:0.005892:0.012657:0.003421:0.003421:0.003421:0.011665:0.011203:0.010434:0.011118:0.005901:0.008244:0.004738:0.005889:0.008518:0.011665:0.003421:0.010434:0.011682:0.003421:0.005901:0.006636:0.010399:0.005164:0.011511:0.011118:0.005148:0.009168:0.005887:0.005371:0.011203:0.005148:0.005886:0.011665:0.011682:0.003421:0.005679
liation in  malignant  spinal cord  compres-:@0.560589:0.751501:0.915153:0.751501:0.915153:0.737495:0.560589:0.737495:0.003421:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.008432:0.003421:0.010434:0.004738:0.003684:0.016044:0.011682:0.003421:0.003421:0.011511:0.010434:0.011682:0.010434:0.005798:0.004738:0.003683:0.006636:0.011665:0.003421:0.010434:0.011682:0.003421:0.008432:0.011067:0.011203:0.005039:0.011716:0.004738:0.003684:0.011067:0.011203:0.016044:0.011665:0.005077:0.011118:0.006636:0.005679
sion. :@0.560589:0.765682:0.601759:0.765682:0.601759:0.751677:0.560589:0.751677:0.006636:0.003421:0.011203:0.010434:0.004738:0.004738
Clinical Oncology:@0.601759:0.765682:0.750139:0.765682:0.750139:0.751677:0.601759:0.751677:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.004738:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
. 2010;22:792-800.:@0.750139:0.765682:0.893217:0.765682:0.893217:0.751677:0.750139:0.751677:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
3. :@0.524242:0.779864:0.543193:0.779864:0.543193:0.765859:0.524242:0.765859:0.009476:0.004738:0.004738
  Prewett  S,  Venkitaraman  R.  Metastatic :@0.560589:0.779864:0.919890:0.779864:0.919890:0.765859:0.560589:0.765859:0.004738:-0.004738:0.010126:0.005075:0.011118:0.014214:0.011118:0.005798:0.005798:0.004738:0.009736:0.008518:0.004738:0.004738:0.009741:0.010281:0.011118:0.010434:0.008586:0.003421:0.005798:0.011682:0.005148:0.011682:0.016044:0.011682:0.010434:0.004738:0.009739:0.010382:0.004738:0.004738:0.009741:0.015719:0.011118:0.005798:0.011682:0.006636:0.005798:0.011682:0.005798:0.003421:0.011067:0.004738
spinal cord compression: review of  the :@0.560589:0.794046:0.919908:0.794046:0.919908:0.780040:0.560589:0.780040:0.006636:0.011665:0.003421:0.010434:0.011682:0.003421:0.012144:0.011067:0.011203:0.005041:0.011716:0.012144:0.011067:0.011203:0.016044:0.011665:0.005075:0.011118:0.006636:0.006636:0.003421:0.011203:0.010434:0.004738:0.012144:0.005077:0.011118:0.009476:0.003421:0.011118:0.014214:0.012144:0.011203:0.005371:0.004738:0.007394:0.005798:0.010434:0.011118:0.004738
evidence for a radiotherapy dose frac-:@0.560589:0.808227:0.915145:0.808227:0.915145:0.794222:0.560589:0.794222:0.011118:0.009476:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118:0.010776:0.005371:0.011203:0.005148:0.010776:0.011682:0.010776:0.005148:0.011682:0.011716:0.003421:0.011203:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.010776:0.011716:0.011203:0.006636:0.011118:0.010776:0.005371:0.005148:0.011682:0.011067:0.005679
tionation schedule. :@0.560589:0.822409:0.736746:0.822409:0.736746:0.808404:0.560589:0.808404:0.005798:0.003421:0.011203:0.010434:0.011682:0.005798:0.003421:0.011203:0.010434:0.017378:0.006636:0.011067:0.010434:0.011118:0.011716:0.010399:0.003421:0.011118:0.004738:0.004738
Clinical  Oncology. :@0.749386:0.822409:0.919898:0.822409:0.919898:0.808404:0.749386:0.808404:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.004738:0.012656:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738:0.004738
2010 22:222-230.:@0.560589:0.836591:0.694208:0.836591:0.694208:0.822585:0.560589:0.822585:0.009476:0.009476:0.009476:0.009476:0.004755:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
;:@0.598509:0.836591:0.603247:0.836591:0.603247:0.822585:0.598509:0.822585:0.004738
4. :@0.524242:0.850772:0.543193:0.850772:0.543193:0.836767:0.524242:0.836767:0.009476:0.004738:0.004738
  Prasad D. Schiff D. Malignant spinal cord :@0.560589:0.850772:0.919895:0.850772:0.919895:0.836767:0.560589:0.836767:0.004738:-0.004738:0.010126:0.005148:0.011682:0.006636:0.011682:0.011716:0.008005:0.012726:0.004738:0.008005:0.008518:0.011067:0.010434:0.003421:0.005422:0.005371:0.008005:0.012726:0.004738:0.008005:0.015719:0.011682:0.003421:0.003421:0.011511:0.010434:0.011682:0.010434:0.005798:0.008005:0.006636:0.011665:0.003421:0.010434:0.011682:0.003421:0.008005:0.011067:0.011203:0.005041:0.011716:0.004738
compression. :@0.560589:0.864954:0.674569:0.864954:0.674569:0.850949:0.560589:0.850949:0.011067:0.011203:0.016044:0.011665:0.005077:0.011118:0.006636:0.006636:0.003421:0.011203:0.010434:0.004738:0.004738
Lancet Oncol:@0.674569:0.864954:0.788295:0.864954:0.788295:0.850949:0.674569:0.850949:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.004738:0.014864:0.010434:0.011067:0.011203:0.003421
. 2005;6:15-24.:@0.788282:0.864954:0.902932:0.864954:0.902932:0.850949:0.788282:0.850949:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
5. :@0.524242:0.879136:0.543193:0.879136:0.543193:0.865130:0.524242:0.865130:0.009476:0.004738:0.004738
  Barrett A, Dobbs J, Morris S, :@0.560589:0.879136:0.792797:0.879136:0.792797:0.865130:0.560589:0.865130:0.004738:-0.004738:0.009818:0.011682:0.005148:0.005080:0.011118:0.005798:0.005798:0.005644:0.012657:0.004738:0.005644:0.012726:0.011203:0.011665:0.011665:0.006636:0.005644:0.008244:0.004738:0.005644:0.015719:0.011203:0.005148:0.005148:0.003421:0.006636:0.005644:0.008518:0.004738:0.004738
et al Practical :@0.793704:0.879136:0.919883:0.879136:0.919883:0.865130:0.793704:0.865130:0.011118:0.005798:0.005644:0.011682:0.003421:0.010365:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011682:0.003421:0.004738
. :@0.831368:0.879136:0.840844:0.879136:0.840844:0.865130:0.831368:0.865130:0.004738:0.004738
Radiotherapy Planning:@0.560589:0.893317:0.756485:0.893317:0.756485:0.879312:0.560589:0.879312:0.010382:0.011682:0.011716:0.003421:0.011203:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.011015:0.010126:0.003421:0.011682:0.010434:0.010434:0.003421:0.010434:0.011511
. 4th ed. London: :@0.756485:0.893317:0.919917:0.893317:0.919917:0.879312:0.756485:0.879312:0.004738:0.011015:0.009476:0.005798:0.010434:0.011015:0.011118:0.011716:0.004738:0.011015:0.007902:0.011203:0.010434:0.011716:0.011203:0.010434:0.004738:0.004738
Hodder Arnold; 2009.:@0.560589:0.907499:0.734952:0.907499:0.734952:0.893494:0.560589:0.893494:0.011682:0.011203:0.011716:0.011716:0.011118:0.005148:0.004738:0.012657:0.005492:0.010434:0.011203:0.003421:0.011716:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
6. :@0.524242:0.921681:0.543193:0.921681:0.543193:0.907675:0.524242:0.907675:0.009476:0.004738:0.004738
  Patchell RA, Tibbs PA, Regine WF, :@0.560589:0.921681:0.843177:0.921681:0.843177:0.907675:0.560589:0.907675:0.004738:-0.004738:0.010126:0.011682:0.005798:0.011067:0.010434:0.011118:0.003421:0.003421:0.006043:0.010382:0.012657:0.004738:0.006036:0.007808:0.003421:0.011665:0.011665:0.006636:0.006055:0.008853:0.012657:0.004738:0.006038:0.010382:0.011118:0.011511:0.003421:0.010434:0.011118:0.006043:0.016420:0.006205:0.004738:0.004738
et al:@0.844470:0.921681:0.882529:0.921681:0.882529:0.907675:0.844470:0.907675:0.011118:0.005798:0.006040:0.011682:0.003421
. Di-:@0.882529:0.921681:0.915135:0.921681:0.915135:0.907675:0.882529:0.907675:0.004738:0.006043:0.012726:0.003421:0.005679
rect  decompressive surgical resection  in :@0.560589:0.935862:0.919896:0.935862:0.919896:0.921857:0.560589:0.921857:0.005078:0.011118:0.011067:0.005798:0.004738:0.005886:0.011716:0.011118:0.011067:0.011203:0.016044:0.011665:0.005075:0.011118:0.006636:0.006636:0.003421:0.009476:0.011118:0.010639:0.006636:0.010399:0.005164:0.011511:0.003421:0.011067:0.011682:0.003421:0.010639:0.005078:0.011118:0.006636:0.011118:0.011067:0.005798:0.003421:0.011203:0.010434:0.004738:0.005886:0.003082:0.010434:0.004738